FORA Capital’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$808K Buy
+13,838
New +$816K 0.03% 348
2022
Q3
– Sell
-41,084
Closed -$1.73M – 540
2022
Q2
$1.73M Buy
41,084
+30,623
+293% +$1.26M 0.34% 88
2022
Q1
$408K Buy
+10,461
New +$411K 0.07% 322
2021
Q3
– Sell
-14,877
Closed -$610K – 770
2021
Q2
$610K Buy
+14,877
New +$633K 0.11% 218
2021
Q1
– Sell
-42,348
Closed -$2.12M – 1048
2020
Q4
$2.12M Buy
+42,348
New +$1.8M 0.32% 64

Other funds holding RPRX

FORA Capital's RPRX Position: Q3 2026 in Review

FORA Capital opened a new position in Royalty Pharma (RPRX) in Q3 2026: 13,838 shares worth $808K. The stake represents 0.03% of the portfolio and ranks #348 among its holdings. This is a return to the name: FORA Capital previously reported a position in RPRX as recently as Q2 2022.

FORA Capital first reported a position in RPRX in Q4 2020 and has held it in 5 quarters since. The position peaked at $2.12M in Q4 2020. 629 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • FORA Capital held 13,838 shares of Royalty Pharma worth $808K as of Q3 2026.
  • Royalty Pharma was a new FORA Capital position in Q3 2026.
  • Royalty Pharma made up 0.03% of FORA Capital's portfolio in Q3 2026, its #348 holding.
  • FORA Capital first reported a position in Royalty Pharma in Q4 2020 and has held it in 5 quarters since.
  • FORA Capital's Royalty Pharma position peaked at $2.12M in Q4 2020.
  • 629 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on FORA Capital's 13F filing for Q3 2026, filed 13 Nov 2026.